Pas Pro

Preserving Affordability: Pharmacy Benefit Management Hits US$ 697.8 Billion by 2030

Pharmacy Benefit Management Market Trends and Overview

The estimated size of the Pharmacy Benefit Management Market was USD 451.3 billion in 2022. It is projected to reach USD 697.8 billion by 2030, with a compound annual growth rate (CAGR) of 11.0% during the forecast period from 2023 to 2030.

This market has witnessed significant growth and is expected to continue its upward trajectory in the coming years. The increasing demand for efficient and cost-effective healthcare solutions has been a key driver for the expansion of the Pharmacy Benefit Management Market.

Pharmacy Benefit Management (PBM) plays a crucial role in managing prescription drug benefits for various stakeholders, including health insurance providers, employers, and government agencies. PBMs help in optimizing drug utilization, reducing costs, and improving patient outcomes.

The rising prevalence of chronic diseases, coupled with the growing aging population, has led to a surge in the demand for prescription drugs. This has further fueled the need for effective management of pharmacy benefits, driving the growth of the PBM market.

Moreover, advancements in technology and the integration of digital solutions have revolutionized the PBM industry. The adoption of electronic health records, telemedicine, and mobile applications has streamlined the process of managing pharmacy benefits, enhancing efficiency and convenience for both patients and healthcare providers.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/3943

Furthermore, the COVID-19 pandemic has highlighted the importance of pharmacy benefit management in ensuring the availability and accessibility of essential medications. The crisis has underscored the need for robust systems that can efficiently handle the distribution and administration of drugs, further boosting the demand for PBM services.

In conclusion, the Pharmacy Benefit Management Market is poised for substantial growth in the coming years. With increasing healthcare needs and the continuous development of innovative solutions, the market is expected to witness a significant expansion, reaching USD 697.8 billion by 2030, at a CAGR of 11.0% during the forecast period of 2023-2030.

KEY MARKET SEGMENTATION:

By Service

  • Retail pharmacy services
  • Specialty pharmacy services
  • Benefit plan design & consultation
  • Others

By End User

  • Healthcare Providers
  • Employers

KEY PLAYERS:

The major key players are Abarca Health LLC, CVS Health, Express Scripts, Humana Pharmacy Solutions, Magellan Rx Management, Anthem Inc., McKesson Corporation, Medimpact Healthcare, MeridianRx, OptumRx (UnitedHealth), Prime Therapeutics, Sea Rainbow, Vidalink, Centene Corporation, and Others.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com